Source link : https://www.newshealth.biz/health-news/ema-endorses-two-adhd-treatments-for-children/
Two treatments for children with attention-deficit hyperactivity disorder (ADHD) have been recommended by the European Medicines Agency (EMA) to receive marketing authorizations. Paxneury for ADHD Symptoms The agency’s Committee for Medicinal Products for Human Use (CHMP) said it was satisfied that Paxneury (guanfacine) reduces behavioral symptoms of ADHD such as hyperactivity, impulsivity, short attention span, […]
Author : News Health
Publish date : 2024-12-13 18:13:59
Copyright for syndicated content belongs to the linked Source.